-+ 0.00%
-+ 0.00%
-+ 0.00%
College of Medicine at Princess Nourah bint Abdulrahman University Signs Memorandum of Understanding with Cellenkos, Inc. to Advance Clinical Trials and Cell and Gene Therapies
Share
Listen to the news

PNU and Cellenkos sign MOU to advance education and training focused on clinical trials and CAGT

HOUSTON, Nov. 9, 2026 /PRNewswire/ -- Cellenkos Inc., a clinical stage biotechnology company, is pleased to share that The College of Medicine at Princess Nourah bint Abdulrahman University has signed a Memorandum of Understanding (MoU) with Cellenkos, Inc. to strengthen collaboration in clinical trials, cell and gene therapies, biomanufacturing technologies, and other areas of mutual interest.

Cellenkos™ logo

The collaboration encompasses curriculum design, the training program development, virtual training sessions, live seminars, and workshops focused on clinical trials. It also provides opportunities to train students in scientific research. The College of Medicine was represented at the signing by its Dean, Dr. Reem AlHarbi, while Cellenkos, Inc. was represented by its Chief Operating Officer, Ms. Tara Sadeghi.

The Memorandum of Understanding (MoU) aims to achieve the shared objectives of both parties to strengthen international partnerships in education, training, and scientific research; develop qualified professionals in clinical trials and cell and gene therapies; and enhance communication and collaboration to support the development of human capabilities.

Cellenkos is thankful to Ministry of Investment, Saudi Arabia (MISA) for supporting this initiative. The MOU was signed at the Riyadh Global Medical Biotechnology Summit (RGMBS)/ Ministry of National Guard Health Affairs (MNGHA). Under the MOU, the inaugural workshop is planned to take place in the first quarter of year 2027.

About Cellenkos

Cellenkos is a clinical stage biotechnology company developing allogeneic tissue directed, cord blood derived T-regulatory cell therapies to resolve inflammation in autoimmune, neurodegenerative and inflammatory diseases. For more information: www.cellenkosinc.com 

About Princess Nourah bint Abdulrahman University

PNU is the largest public women's university in the world, established in 1970. The university offers diplomas, bachelor and postgraduate degrees. It has 34 colleges in the city of Riyadh and in the neighboring cities, an Arabic Language Institute (for non-speakers of Arabic), a Deanship of Community Service and Continuous Education, and a Community College. It has more than 5,000 academic and administrative staff. For more information: https://pnu.edu.sa

Media contact: contact@cellenkosinc.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/college-of-medicine-at-princess-nourah-bint-abdulrahman-university-signs-memorandum-of-understanding-with-cellenkos-inc-to-advance-clinical-trials-and-cell-and-gene-therapies-302932824.html

SOURCE Cellenkos, Inc.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending